Cambridge Investment Research Advisors, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19
-52.5%
30,8540.0%0.00%
Q2 2023$40
-25.9%
30,8540.0%0.00%
Q1 2023$54
-44.3%
30,8540.0%0.00%
-100.0%
Q4 2022$97
-99.9%
30,854
-0.2%
0.00%0.0%
Q3 2022$151,000
+18.0%
30,9120.0%0.00%0.0%
Q2 2022$128,000
-23.8%
30,912
+7.1%
0.00%0.0%
Q1 2022$168,000
-22.6%
28,862
-0.3%
0.00%0.0%
Q4 2021$217,000
-18.4%
28,962
-1.8%
0.00%0.0%
Q3 2021$266,000
-24.9%
29,504
-0.2%
0.00%
-50.0%
Q2 2021$354,000
-18.8%
29,573
-15.0%
0.00%0.0%
Q1 2021$436,000
-19.7%
34,8060.0%0.00%
-33.3%
Q4 2020$543,000
+91.9%
34,806
+16.2%
0.00%
+50.0%
Q3 2020$283,000
+5.2%
29,945
-0.3%
0.00%0.0%
Q2 2020$269,000
+40.8%
30,0450.0%0.00%0.0%
Q1 2020$191,000
-23.9%
30,0450.0%0.00%0.0%
Q4 2019$251,000
+21.3%
30,045
+31.1%
0.00%0.0%
Q3 2019$207,000
-1.4%
22,920
+17.6%
0.00%0.0%
Q2 2019$210,000
+14.1%
19,486
+1.0%
0.00%0.0%
Q1 2019$184,000
-1.6%
19,286
+18.3%
0.00%0.0%
Q4 2018$187,000
+2.7%
16,296
+52.1%
0.00%0.0%
Q3 2018$182,00010,7160.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders